More Videos:

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Will Insiders Be Tempted To Buy More SNTA At The New 52-Week Low?

Tickers in this article: SNTA
In trading on Wednesday, shares of Synta Pharmaceuticals Corp touched a new 52-week low of $3.70/share. That's a $8.18 share price drop, or -68.86% decline from the 52-week high of $11.88 set back on 01/29/2013. Large percentage drops always require that the stock post even larger percentage gains from the low in order to recover the old price point, and for SNTA that means the stock would have to gain 221.08% to get back to the 52-week high. For a move like that, Synta Pharmaceuticals Corp would need fundamental strength at the business level.

Here's a rhetorical question: Who knows more about fundamentals at the business level than the company's own insiders? So let's take a look to see whether any company insiders were taking the other side of the trade as SNTA shares were being sold down to this new 52-week low, focusing on the most recent trailing six month period. As summarized by the table below, SNTA has seen 4 different instances of insiders buying over the past six months.

Ten Bargains You Can Buy Cheaper Than The Insiders Did »

Purchased Insider Title Shares Price/Share Value
06/05/2013 Vojo Vukovic SVP, Chief Medical Officer 10,000 $4.58 $45,800.00
06/04/2013 Robert N. Wilson Director 10,000 $5.00 $50,000.00
06/06/2013 Safi R. Bahcall President and CEO 10,000 $4.04 $40,390.00
06/06/2013 Bruce Kovner Director 2,000,000 $4.64 $9,270,353.63
06/14/2013 Safi R. Bahcall President and CEO 10,000 $4.05 $40,550.00
06/18/2013 Bruce Kovner Director 200,000 $4.00 $799,160.00
06/21/2013 Safi R. Bahcall President and CEO 20,000 $4.12 $82,374.00
06/24/2013 Bruce Kovner Director 250,000 $4.39 $1,097,440.00
06/26/2013 Bruce Kovner Director 500,000 $4.53 $2,265,390.00
06/28/2013 Safi R. Bahcall President and CEO 10,000 $5.03 $50,299.00
06/27/2013 Bruce Kovner Director 150,000 $4.71 $706,515.00

In the short run, while the new 52-week low suggests the stock is at the cheapest price and perhaps therefore the best bargain it has been over the last 52 weeks, the low print also means anyone who has purchased the stock over that timeframe is staring at an unrealized loss. Oftentimes, that factor drives a stock's technical analysis metrics by creating overhead resistance, with investors who bought higher now anxious to reverse their trade once they are back to breakeven. The chart below shows where SNTA has traded over the past year, with the 50-day and 200-day moving averages included.